Allison Wey

last updated 5/7/2018

Allison H. Wey

Vice President, Investor Relations and Corporate Communications at Regulus Therapeutics Inc.

Location:
10614 SCIENCE CENTER DRIVE, San Diego, California, United States
HQ Phone:
(858) 202-6300

General Information

Experience

Vice President IR and Corporate Affairs - Lead411

Vice President, Investor Relations and Public Affairs - Durata Therapeutics Inc

Vice President, Investor Relations and Corporate Affairs - Par Pharmaceutical Companies , Inc.

Education

BA - EconomicsMarketing , Drake University

Recent News  

Joseph "Jay" Hagan - Regulus Therapeutics

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications

Read More
Allison Wey - Regulus Therapeutics

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications Allison Wey In May, 2016, Allison Wey was appointed Vice President, Investor Relations and Corporate Communications for Regulus Therapeutics. Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations, and investment banking. Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey also worked in media relations and corporate communications leadership roles including VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc.

Read More
Allison Wey - Regulus Therapeutics

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications Allison Wey In May, 2016, Allison Wey was appointed Vice President, Investor Relations and Corporate Communications for Regulus Therapeutics. Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations, and investment banking. Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey also worked in media relations and corporate communications leadership roles including VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc.

Read More

Browse ZoomInfo’s Directories